HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal Administration of Antiviral Agents in Silicone Oil-Filled Human Eyes.

AbstractPURPOSE:
To report our experience with intra-silicone oil (SO) injection of antiviral agents for treatment of viral retinitis and to review the relevant literature.
DESIGN:
Two case reports and a literature review.
PARTICIPANTS:
Two patients with viral retinitis and SO tamponade.
METHODS:
Two patients with viral retinitis were treated with intravitreal injections of low-dose ganciclovir (2 mg/0.05 ml), foscarnet (1.2 mg/0.05 ml), or both after retinal detachment repair with SO tamponade, in addition to systemic antiviral therapy from 2014 through 2015. The literature on the use of intraocular antiviral agents in the setting of SO vitreous substitute was reviewed.
MAIN OUTCOME MEASURES:
Clinical outcomes after administration of intra-SO antiviral therapy.
RESULTS:
A patient with progressive outer retinal necrosis received 5 intra-SO injections of low-dose ganciclovir and foscarnet after surgery over 6 weeks. Another patient with acute retinal necrosis received weekly low-dose foscarnet injections into his SO-filled eye for 8 weeks after surgery. Significant retinitis regression with long-term retinitis control was achieved in both patients throughout follow-up. No articles reporting the administration of soluble antiviral agents into an SO-filled human eye were identified.
CONCLUSIONS:
Our preliminary findings indicate that administration of low-dose ganciclovir and foscarnet into an SO-filled eye may be used as adjunctive treatment for viral retinitis. Further studies are needed to confirm these results.
AuthorsAmit Meshi, Asaf Friehmann, Sarah Sella, Raz Gepstein, Sharon Armarnik, Ehud I Assia, Alexander Rubowitz
JournalOphthalmology. Retina (Ophthalmol Retina) 2017 Jul - Aug Vol. 1 Issue 4 Pg. 288-293 ISSN: 2468-6530 [Electronic] United States
PMID31047514 (Publication Type: Journal Article)
CopyrightCopyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: